INTERACTIVE BOARDROOM: COLLABORATE, SOLVE, SHARE šŸ¤

AI is powerful, but the drug and the patientĀ comeĀ first.Ā This boardroom explores how teams canĀ leverageĀ AI safely, integrate it into workflows, andĀ maintainĀ human control with strong processes.

Shift from “random prompting” to building Structured Supply Chain AI Workflows that save hours while keeping human oversight and data security intact

Outcome:Ā Each table will collaborate to createĀ practicalĀ strategies,Ā and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.

 

ASK THE EXPERT PANEL: How to choose CDMOs as a true extension of your team to enable flexible, and stage-specific clinical supply needs šŸ“Š LIVE POLL

  • How to align CDMO partnerships with phase-specific needs while staying agile
  • How to collaborate across CDMOs and ensure smooth tech transitions, especially forĀ biologics therapies
  • How to build transparent CDMO partnerships from Day 1 to overcome challenges and save costs

Moderator: Amanda Murphy, Head of Digital Product Management, GlobalData

  • Panelist 1: Aimee Hogue, Director Supply Chain, Sutro Biopharma
  • Panelist 2: Amber Bill, Associate Director, Sangamo TherapeuticsĀ Ā 

Panelist 3: Burkard Kolb, Former Executive Director, CMC Operations, 89bioĀ  (Genentech)Ā 

CASE STUDY: Streamlining E2E Supply Complexity: Implementing Robust S&OP Governance Across the Value Chain

  • Aligning Supply Chain, CMC, Clinical Operations, Regulatory, Quality, and Finance to evaluate options, trade-offs, risk, and cost and align on an integrated path forward
  • Establishing S&OP governance, ownership, and decision rights linking supply execution with financial planning to drive transparency, accountability, and aligned decisions
  • Creating end-to-end visibility to identify constraints early, improve agility, mitigate risk, and maintain supply continuity across clinical and commercial programs

INTERACTIVE KEYNOTE: The Forecast Is Dead: Clinical Supply’s Shift from Prediction to Continuous Orchestration

  • From forecasting to continuous supply intelligence: why the real metric is decision latency, the time between a supply signal and a supply action, and how leading sponsors are collapsing it from weeks to hours
  • The connected ecosystem in practice: how event-driven supply orchestration (IRT working in concert with eCOA, depots, couriers, and temperature data) turns thousands of small, automated decisions into fewer shipments, leaner stock, and uninterrupted patient dosing.
  • You vs. the algorithm (live)

 

OPENING REGULATORY KEYNOTE: Ensuring Clinical Trial Continuity – Navigating the Importation of Pharmaceuticals, Biologics, Medical Devices & Combination Products

  • Understand current importation requirements and regulatory considerations for pharmaceuticals, biologics, medical devices, and combination products used in clinical research.
  • Learn practical strategies and best practices to prevent shipment delays, mitigate compliance risks, and maintain continuity of clinical trial supplies across global supply chains.
  • Explore how to navigate the FDA imports process from entry submission to compliance determination

 

Drinks reception

šŸ·Ā Drinks reception –Ā Unwind and network while enjoying some of California’s finest wines

šŸ†Ā PRIZE DRAW: Visit our exhibitors’ booths throughout the day and collect stamps to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!